Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer

BACKGROUND: The accurate evaluation of favorable response to neoadjuvant chemotherapy (NCT) is critical to determine the extent of surgery. We investigated independent clinicopathological and radiological predictors to discriminate no residual carcinoma (ypT0) from residual ductal carcinoma in situ...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seho, Yoon, Jung Hyun, Sohn, Joohyuk, Park, Hyung Seok, Moon, Hee Jung, Kim, Min Jung, Kim, Eun-Kyung, Kim, Seung Il, Park, Byeong-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750980/
https://www.ncbi.nlm.nih.gov/pubmed/26866475
http://dx.doi.org/10.1371/journal.pone.0149347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750980/
https://www.ncbi.nlm.nih.gov/pubmed/26866475
http://dx.doi.org/10.1371/journal.pone.0149347

Ejemplares similares